(Q28647898)

6

object named as

David Wendler

0 references

Annette Rid

5

object named as

Annette Rid

0 references

author name string

Gabriella Bedarida

2

0 references

Kristy Macci

3

0 references

Nicole B Gabler

Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical Trials

4

0 references

language of work or name

English

0 references

publication date

26 June 2015

0 references

published in

The BMJ

0 references

volume

350

0 references

issue

jun26 2

0 references

page(s)

h3271

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

Comprehension and informed consent: assessing the effect of a short consent form

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

Gender differences in drug toxicity

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

Balancing justice and autonomy in clinical research with healthy volunteers

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

Money and distorted ethical judgments about research: ethical assessment of the TeGenero TGN1412 trial

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

Strategies to minimize risks and exploitation in phase one trials on healthy subjects

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

What makes clinical research ethical?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

Healthy volunteer studies in Great Britain: the results of a survey into 12 months activity in this field

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

Informative inducement: study payment as a signal of risk.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

Risks and benefits of phase 1 oncology trials, 1991 through 2002.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

Justice for the Professional Guinea Pig

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4482145

Exploiting a research underclass in phase 1 clinical trials

27 November 2018

1 reference

12 December 2020

TeGenero fiasco prompts regulatory rethink

1 reference

12 December 2020

Adverse events in volunteers participating in phase I clinical trials: a single-center five-year survey in 1,559 subjects

1 reference

12 December 2020

Adverse events in phase-I studies: a report in 1015 healthy volunteers

1 reference

12 December 2020